Chapter 70.14 - HEALTH CARE SERVICES PURCHASED BY STATE AGENCIES
- Section 70.14.020 - State agencies to identify alternative health care providers
- Section 70.14.030 - Health care utilization review procedures
- Section 70.14.040 - Review of prospective rate setting methods
- Section 70.14.050 - Drug purchasing cost controls-Establishment of evidence-based prescription drug program
- Section 70.14.060 - Prescription drug purchasing consortium-Participation-Exceptions-Rules
- Section 70.14.065 - Generic prescription drug partnership agreements
- Section 70.14.070 - Prescription drug consortium account
- Section 70.14.080 - Definitions
- Section 70.14.090 - Health technology clinical committee
- Section 70.14.100 - Health technology selection and assessment
- Section 70.14.110 - Health technology clinical committee determinations
- Section 70.14.120 - Agency compliance with committee determination-Coverage and reimbursement determinations for nonreviewed health technologies-Appeals
- Section 70.14.130 - Health technology clinical committee-Public notice
- Section 70.14.140 - Applicability to health care services purchased from health carriers
- Section 70.14.150 - Data-sharing agreements-Report
- Section 70.14.155 - Streamlined health care administration-Agency participation
- Section 70.14.160 - [Expires 12/1/2024] Total cost of insulin work group-Appointment-Duties-Reporting
- Section 70.14.165 - Total cost of insulin work group-Authority implementation
- Section 70.14.170 - Opioid overdose reversal medications-Bulk purchasing and distribution-Rules-Report-Recommendation to legislature
- Section 70.14.175 - Opioid overdose reversal medication account